NCVLX | VMVAX | NCVLX / VMVAX | |
Total Expense Ratio | 1.04 | 0.07 | 1,486% |
Annual Report Gross Expense Ratio | 1.13 | 0.07 | 1,614% |
Fund Existence | 14 years | 14 years | - |
Gain YTD | 1.154 | 3.573 | 32% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111M | 29.9B | 0% |
Annual Yield % from dividends | 1.27 | 2.26 | 56% |
Returns for 1 year | 4.00 | 12.14 | 33% |
Returns for 3 years | -0.26 | 28.52 | -1% |
Returns for 5 years | 1.55 | 77.08 | 2% |
Returns for 10 years | 2.48 | 88.11 | 3% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CIPSX | 22.15 | 0.19 | +0.87% |
Champlain Small Company Adv | |||
RYDAX | 106.07 | 0.83 | +0.79% |
Rydex Dow Jones Industrial Average® A | |||
AWSRX | 16.94 | 0.11 | +0.65% |
Invesco Global Core Equity R | |||
SCAUX | 11.53 | 0.06 | +0.52% |
Invesco Income Advantage U.S. Fund A | |||
AMVGX | 16.23 | 0.04 | +0.25% |
American Century Mid Cap Value R5 |